Gain Therapeutics Inc. (GANX)
Market Closed
12 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
4. 14
+0.03
+0.73%
$
113.34M Market Cap
- P/E Ratio
0% Div Yield
1,819,575 Volume
-1.19 Eps
$ 4.11
Previous Close Day Range
4.03 4.29
Year Range
1.41 4.34
Want to track GANX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| GANX Gain Therapeutics Inc. 13 Nov 2025 | | - | - |
| GANX Gain Therapeutics Inc. 7 Nov 2025 | | - | - |
| GANX Gain Therapeutics Inc. 7 Aug 2025 | | - | - |
| GANX Gain Therapeutics Inc. 12 May 2025 | | - | - |
| GANX Gain Therapeutics Inc. 24 Mar 2025 | | - | - |
| GANX Gain Therapeutics Inc. 12 Nov 2024 | | - | - |
| GANX Gain Therapeutics Inc. 8 Aug 2024 | | - | - |
| GANX Gain Therapeutics Inc. 24 Jun 2024 | | - | - |
| GANX Gain Therapeutics Inc. 21 Mar 2024 | | - | - |
| GANX Gain Therapeutics Inc. 8 Nov 2023 | | - | - |
GANX Earnings Reports FAQ
What is the earnings per share (EPS) for GANX?
The current EPS is -1.19.
What is the company's earnings growth rate?
Gain Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Gain Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Gain Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GANX at this time, as Gain Therapeutics Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
